Intelligent Bio Solutions (INBS) Total Current Liabilities (2020 - 2025)

Intelligent Bio Solutions' Total Current Liabilities history runs 6 years deep, the most recent figure standing at $5.4 million for Q2 2025.

• In Q2 2025, Total Current Liabilities fell 1.83% year-over-year to $5.4 million; the TTM figure through Jun 2025 stood at $5.4 million (down 1.83% YoY), while the FY2025 annual figure was $5.4 million, down 1.83% from the prior year.
• Total Current Liabilities was $5.4 million for Q2 2025 at Intelligent Bio Solutions, up from $4.6 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $6.8 million in Q3 2023 to a low of $1.6 million in Q1 2021.
• Historically, Total Current Liabilities has averaged $4.5 million across 5 years, with a median of $4.6 million in 2022.
• Biggest YoY gain for Total Current Liabilities was 243.73% in 2021; the steepest drop was 52.11% in 2021.
• A 5-year view of Total Current Liabilities shows it stood at $4.0 million in 2021, then gained by 20.08% to $4.8 million in 2022, then rose by 7.65% to $5.2 million in 2023, then declined by 15.06% to $4.4 million in 2024, then advanced by 21.54% to $5.4 million in 2025.
• The last three Total Current Liabilities figures came in at $5.4 million (Q2 2025), $4.6 million (Q1 2025), and $4.4 million (Q4 2024), per Business Quant data.